ANALYSIS: How GSK’s Canada SC hearing unfolded

The Supreme Court of Canada met last week to hear the Canada Revenue Agency's (CRA) appeal and GlaxoSmithKline’s (GSK) response in a case about whether the taxpayer paid too much for active pharmaceutical ingredients (API) from a Swiss associated enterprise.